Neoadjuvant Gemcitabine and Cisplatin in Combination With Perioperative Pembrolizumab Versus Upfront Surgery for Patients With Primary Resectable and Borderline Resectable Perihilar and Distal Cholangiocarcinoma

Clinical trial NCT06923475 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06923475
Sponsor: Amsterdam UMC, location VUmc
Status: NOT_YET_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Extrahepatic Cholangiocarcinoma Perihilar Cholangiocarcinoma Distal Cholangiocarcinoma Resectable Borderline Resectable

Start date: 2025-05-05
Primary completion: 2028-11-06
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.